title: [Latanoprost (Xalatan) and a systemic respiratory effect? Apropos of a case].
authors.forename: G
authors.initials: G
authors.lastname: Veyrac
authors.forename: A
authors.initials: A
authors.lastname: Chiffoleau
authors.forename: L
authors.initials: L
authors.lastname: Cellerin
authors.forename: C
authors.initials: C
authors.lastname: Larousse
authors.forename: M
authors.initials: M
authors.lastname: Bourin
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced; D016535:Bronchial Hyperreactivity / Q000139:chemically induced; D001986:Bronchial Spasm / Q000139:chemically induced; D004342:Drug Hypersensitivity / Q000209:etiology*; D005902:Glaucoma, Open-Angle / Q000150:complications / Q000188:drug therapy; D006801:Humans; D000077338:Latanoprost; D008297:Male; D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic / Q000009:adverse effects*; D017482:Receptors, Thromboxane / Q000187:drug effects / Q000502:physiology; D012130:Respiratory Hypersensitivity / Q000139:chemically induced*
chemical_list: D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic; D017482:Receptors, Thromboxane; D000077338:Latanoprost